Search
Avalyn Pharma Ord Shs (Proposed)
AVLNAdd to Watchlist
30.280USD
-0.310-1.01%
Close 11-13 16:00（ET）
1.34BMarket Cap
0.00P/E TTM
AVLN Analyst Recommendation Trends
In the current month, AVLN has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AVLN average Analyst price target in the last month is 61.800.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2
2
2
2
0
0
0
0
3
2
2
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
4
4
4
1
0
0
0
Financial Forecasting
Based on analysts' estimates, AVLN EPS is projected to reach -0.833 in FY2026Q4, following reported EPS of -0.669 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
--
-0.81
-0.71
-0.83
Actual
-21.83
-0.98
-0.67
--
Surprise
--
-20.48%
+6.27%
--
FAQs
What is the analyst rating for Avalyn Pharma Ord Shs (Proposed)?
Based on the ratings of Avalyn Pharma Ord Shs (Proposed)'s stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.